SCHEMBL962610

SCHEMBL962610

CCOC(=O)/C(=C\N(C)C)C(=O)C(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.47
NPSR1 Q6W5P4 4/20 0.43
GLO1 Q04760 1/20 0.43
ALDH1A1 P00352 3/20 0.39
CYP2D6 P10635 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAPT P10636 6/20 0.38
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
LMNA P02545 3/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
S1PR4 O95977 1/20 0.35
S1PR1 P21453 1/20 0.35
MAPK1 P28482 1/20 0.35
USP2 O75604 1/20 0.35
IDE P14735 1/20 0.35
TNNI3 P19429 1/20 0.35
TNNT2 P45379 1/20 0.35
TNNC1 P63316 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12081760 1.00 CYP2C9 (0.47) CYP2C9NPSR1GLO1ALDH1A1CYP2D6
SCHEMBL962611 1.00 CYP2C9 (0.47) CYP2C9NPSR1GLO1ALDH1A1CYP2D6
SCHEMBL3589914 0.88 CYP2C9 (0.46) CYP2C9NPSR1GLO1ALDH1A1CYP2D6
SCHEMBL13100602 0.87 NPSR1 (0.41) CYP2C9NPSR1GLO1ALDH1A1CYP2D6
SCHEMBL18936293 0.85 NPSR1 (0.42) CYP2C9NPSR1GLO1ALDH1A1CYP2D6
SCHEMBL18936291 0.85 NPSR1 (0.42) CYP2C9NPSR1GLO1ALDH1A1CYP2D6
SCHEMBL1587531 0.84 CYP2C9 (0.49) CYP2C9NPSR1GLO1ALDH1A1CYP2D6
SCHEMBL5901707 0.84 CYP2C9 (0.49) CYP2C9NPSR1GLO1ALDH1A1CYP2D6
SCHEMBL1587530 0.84 CYP2C9 (0.49) CYP2C9NPSR1GLO1ALDH1A1CYP2D6
SCHEMBL18936345 0.84 CYP2C9 (0.43) CYP2C9NPSR1GLO1ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009642-A1 Method for the Regioselective Synthesis of 1-Alkyl-3-haloalkyl-pyrazole-4-carboxylic Acid Derivatives BAYER CROPSCIENCE AG (DE) 2011-01-13 US claimed
EP-3178813-A1 METHOD FOR PREPARING HALOGENATED 3-OXOCARBOXYLATES CARRYING A 2-ALKOXYMETHYLIDENE OR A 2-DIALKYLAMINOMETHYLIDENE GROUP BASF SE (DE) 2017-06-14 EP disclosed
US-9012657-B2 Method for producing pyrazole compound CENTRAL GLASS COMPANY, LIMITED (JP) 2015-04-21 US disclosed
US-20140107347-A1 Method for Producing Pyrazole Compound CENTRAL GLASS COMPANY, LIMITED (JP) 2014-04-17 US disclosed
US-8629288-B2 Method for the regioselective synthesis of 1-alky1-3-haloalkyl-pyrazole-4-carboxylic acid derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-01-14 US disclosed
US-8592605-B2 Method for the regioselective synthesis of 1-Alkyl-3-haloalkyl-pyrazole-4-carboxylic acid derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-11-26 US disclosed
US-20130197239-A1 Method for the Regioselective Synthesis of 1-Alkyl-3-Haloalkyl-Pyrazole-4-Carboxylic Acid Derivatives BAYER CROPSCIENCE AG (DE) 2013-08-01 US disclosed
US-8288582-B2 Method for the production of 2-fluoroacyl-3-aminoacrylic acid derivatives BAYER CROPSCIENCE AG (DE) 2012-10-16 US disclosed
US-8258335-B2 Process for preparing 2-dihaloacyl-3-aminoacrylic acid derivatives BAYER CROPSCIENCE AG (DE) 2012-09-04 US disclosed
US-20110009642-A1 Method for the Regioselective Synthesis of 1-Alkyl-3-haloalkyl-pyrazole-4-carboxylic Acid Derivatives BAYER CROPSCIENCE AG (DE) 2011-01-13 US disclosed
EP-1678119-B1 METHOD FOR PRODUCING 2-DIHALOACYL-3-AMINO-ACRYLIC ACID ESTERS AND 3-DIHALOMETHYL-PYRAZOLE-4-CARBOXYLIC ACID ESTERS BAYER CROPSCIENCE AG (DE) 2011-01-05 EP disclosed
US-20100274049-A1 Method for the production of 2-fluoroacyl-3-aminoacrylic acid derivatives BAYER CROPSCIENCE AG (DE) 2010-10-28 US disclosed
US-20100204483-A1 PROCESS FOR PREPARING 2-DIHALOACYL-3-AMINOACRYLIC ACID DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2010-08-12 US disclosed
US-7358387-B2 Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl pyrazole-4-carboxylic acid esters BAYER CROPSCIENCE AG (DE) 2008-04-15 US disclosed
US-7358387-B2 Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl pyrazole-4-carboxylic acid esters BAYER CROPSCIENCE AG (DE) 2008-04-15 US disclosed
US-20060252944-A1 Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl pyrazole-4-carboxylic acid esters BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2006-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140107347-A1 Method for Producing Pyrazole Compound AADAC, ALDH7A1, AADAT CYP2C9 60/4885NPSR1 4089/4885GLO1 319/4885
US-20110009642-A1 Method for the Regioselective Synthesis of 1-Alkyl-3-haloalkyl-pyrazole-4-carboxylic Acid Derivatives ATL3, HCAR3, AADAC CYP2C9 422/4885NPSR1 2992/4885GLO1 1936/4885
US-20100204483-A1 PROCESS FOR PREPARING 2-DIHALOACYL-3-AMINOACRYLIC ACID DERIVATIVES AADAT, DDC, IDUA CYP2C9 1949/4885NPSR1 2213/4885GLO1 1177/4885
US-20100274049-A1 Method for the production of 2-fluoroacyl-3-aminoacrylic acid derivatives AADAT, AADAC, ALAD CYP2C9 1453/4885NPSR1 2981/4885GLO1 304/4885
US-20130197239-A1 Method for the Regioselective Synthesis of 1-Alkyl-3-Haloalkyl-Pyrazole-4-Carboxylic Acid Derivatives ATL3, HCAR3, AADAC CYP2C9 422/4885NPSR1 2992/4885GLO1 1936/4885
US-20060252944-A1 Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl pyrazole-4-carboxylic acid esters DDC, IDUA, AADAT CYP2C9 503/4885NPSR1 3425/4885GLO1 1498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.